[1]
Li J-J, Modern Pharmaceutical Synthesis, 2005: 210-211.
Google Scholar
[2]
Chen Y., Yang J. Illustration on Synthesis Route of Montelukast Sodium, Journal of China Medicine, 2009, 40(1): 64-66.
Google Scholar
[3]
Chen Q., He M.J., Liu J.M., progress of study on relationship between leukotrienes and athma, Journal of pediatrics medicine, 2008, 23(16): 1284-1286.
Google Scholar
[4]
Sampson A, Holgate S, Leukotrience modifiers in the treatment of asthma, British Medical Journal, 1998, 316(5): 1257—1258.
Google Scholar
[5]
Bai G.F., Observation on Treatment of Montelukast Sodium for bronchial asthma of the elder[J], Guidance of China Medicine, 2010, 8(8): 76-78.
Google Scholar
[6]
Ying H.X., Observation on Treatment of Montelukast Sodium for serious bronchial asthma of Children[J], Journal of China General Medicine, 2009, 12(3): 245-246.
Google Scholar
[7]
Bagnoli L, Scarponi C, Testaferri L, et al. Preparation of both enantiomers of cyclopropane derivatives from the reaction of vinyl selenones with di-(-)-bornyl malonate[J]. Tetrahedron: Asymmetry 20 (2009) 1506-1514.
DOI: 10.1016/j.tetasy.2009.05.019
Google Scholar
[8]
Yao X.F., Progress on Study Effect of Se on human health [J]. Silicon Valley, 2008, (18): 17-18.
Google Scholar
[9]
Itoh O, Kohmura Y, Ichikawa Y et al. The chemistry of 1, 3-glycol derivatives. III. The Preparation of 1, 1-Bis(1-hydroxyalkyl)cyclopropanes and Their Halogenation[J]. Bulletin of the Chemical Society of Japen, 1980, 53(1): 146-153.
DOI: 10.1246/bcsj.53.146
Google Scholar
[10]
Verhe R, Courtheyn D, Kimpe N D et al. Synthesis of 1, 1-bis (hydroxymethyl) cyclopropanes[J]. Organic Preparations and Procedures International: The New Journal for Organic Synthesis, 1981, 13(1): 13-18.
DOI: 10.1080/00304948109356496
Google Scholar
[11]
Cao F.C., Synthesis and Application of reactive Fire Retardant of 2, 2-bis(bromomethyl)-1, 3-propanediol [J]. Chemical Engineering of Hebei, 1997, (2)19-20.
Google Scholar